메뉴 건너뛰기




Volumn 92, Issue 2, 2011, Pages 183-189

Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients

Author keywords

C reactive protein; Cardiovascular events; Cardiovascular risk factors; Framingham equation; Microalbuminuria; Uric acid

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; URIC ACID;

EID: 79960290458     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821f303f     Document Type: Article
Times cited : (47)

References (22)
  • 1
    • 0034005754 scopus 로고    scopus 로고
    • Long-term survival in renal Transplant recipients with graft function
    • Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal Transplant recipients with graft function. Kidney Int 2000; 57: 307.
    • (2000) Kidney Int , vol.57 , pp. 307
    • Ojo, A.O.1    Hanson, J.A.2    Wolfe, R.A.3
  • 2
    • 0032510639 scopus 로고    scopus 로고
    • Predictionofcoronaryheart disease using risk factor categories
    • Wilson PW, D'Agostino RB, Levy D, et al. Predictionofcoronaryheart disease using risk factor categories. Circulation 1998; 97: 1837.
    • (1998) Circulation , vol.97 , pp. 1837
    • Wilson, P.W.1    D'Agostino, R.B.2    Levy, D.3
  • 3
    • 0033843762 scopus 로고    scopus 로고
    • Explained and unexplained isch-emic heart disease risk after renal transplantation
    • Kasiske BL, Chakkera HA, Roel J. Explained and unexplained isch-emic heart disease risk after renal transplantation. JAm Soc Nephrol 2000; 11: 1735.
    • (2000) JAm Soc Nephrol , vol.11 , pp. 1735
    • Kasiske, B.L.1    Chakkera, H.A.2    Roel, J.3
  • 4
    • 44649087813 scopus 로고    scopus 로고
    • Cardiovascular outcomes in the outpatient kidney transplant clinic: The Framingham Risk Score revisited
    • Kiberd B, Panek R. Cardiovascular outcomes in the outpatient kidney transplant clinic: The Framingham Risk Score revisited. Clin JAm Soc Nephrol 2008; 3: 822.
    • (2008) Clin JAm Soc Nephrol , vol.3 , pp. 822
    • Kiberd, B.1    Panek, R.2
  • 5
    • 75149181301 scopus 로고    scopus 로고
    • Predicting coronary heart disease after kidney transplantation: Patient outcomes in renal transplantation (PORT) study
    • the PORT investigators
    • Israni AK, Snyder JJ, Skeans MA, et al; for the PORT investigators. Predicting coronary heart disease after kidney transplantation: Patient outcomes in renal transplantation (PORT) study. Am J Transplant 2010; 10: 338.
    • (2010) Am J Transplant , vol.10 , pp. 338
    • Israni, A.K.1    Snyder, J.J.2    Skeans, M.A.3
  • 6
    • 33845709506 scopus 로고    scopus 로고
    • Multiple biomarkers for the pre-diction of first major cardiovascular events and death
    • Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the pre-diction of first major cardiovascular events and death. N Engl J Med 2006; 355: 2631.
    • (2006) N Engl J Med , vol.355 , pp. 2631
    • Wang, T.J.1    Gona, P.2    Larson, M.G.3
  • 7
    • 0037078969 scopus 로고    scopus 로고
    • Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction offirst car-diovascular events
    • Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction offirst car-diovascular events. NEngl JMed 2002; 347: 1557.
    • (2002) NEngl JMed , vol.347 , pp. 1557
    • Ridker, P.M.1    Rifai, N.2    Rose, L.3
  • 8
    • 0035948631 scopus 로고    scopus 로고
    • Albu-minuria and risk of cardiovascular events death and heart failure in diabetic and nondiabetic individuals
    • HOPE Study Investigators
    • Gerstein HC, Mann JF, Yi Q, et al; HOPE Study Investigators. Albu-minuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421.
    • (2001) JAMA , vol.286 , pp. 421
    • Gerstein, H.C.1    Mann, J.F.2    Yi, Q.3
  • 9
    • 0034630917 scopus 로고    scopus 로고
    • Serum uric acid and cardiovascular mortality: The NHANES i epidemiologic follow-up study 1971-1992 National Health and Nutrition Examination Survey
    • Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404.
    • (2000) JAMA , vol.283 , pp. 2404
    • Fang, J.1    Alderman, M.H.2
  • 10
    • 3242785541 scopus 로고    scopus 로고
    • Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study
    • Niskanen LK, Laaksonen DE, Nyssonenen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004; 164: 1546.
    • (2004) Arch Intern Med , vol.164 , pp. 1546
    • Niskanen, L.K.1    Laaksonen, D.E.2    Nyssonenen, K.3
  • 11
    • 3042845600 scopus 로고    scopus 로고
    • Predicting coronary heart disease in renal transplant recipients: Aprospective study
    • Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients: Aprospective study. Kidney Int 2004; 66: 441.
    • (2004) Kidney Int , vol.66 , pp. 441
    • Ducloux, D.1    Kazory, A.2    Chalopin, J.M.3
  • 12
    • 33847711876 scopus 로고    scopus 로고
    • Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients
    • Halimi J-M, Buchler M, Al-Najjar A, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant 2007; 7: 618.
    • (2007) Am J Transplant , vol.7 , pp. 618
    • Halimi, J.-M.1    Buchler, M.2    Al-Najjar, A.3
  • 13
    • 53449101073 scopus 로고    scopus 로고
    • Hyperuricemia is associated with the development of the composite outcomes of new cardiovascu-lar events and chronic allograft nephropathy
    • Akalin E, Ganeshan SV, Winston J, et al. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascu-lar events and chronic allograft nephropathy. Transplantation 2008; 86: 652.
    • (2008) Transplantation , vol.86 , pp. 652
    • Akalin, E.1    Ganeshan, S.V.2    Winston, J.3
  • 14
    • 4744366713 scopus 로고    scopus 로고
    • Kidney Transplantation halts cardiovascular disease progression in patients with end-stage renal disease
    • Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Kidney Transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 2004; 4: 1662.
    • (2004) Am J Transplant , vol.4 , pp. 1662
    • Meier-Kriesche, H.U.1    Schold, J.D.2    Srinivas, T.R.3
  • 15
    • 72249113124 scopus 로고    scopus 로고
    • Assessment ofclaims of im-proved prediction beyond the Framingham risk score
    • Tzoulaki I, Liberopoulos G, Ionnidis JP. Assessment ofclaims of im-proved prediction beyond the Framingham risk score. JAMA 2009; 302: 2345.
    • (2009) JAMA , vol.302 , pp. 2345
    • Tzoulaki, I.1    Liberopoulos, G.2    Ionnidis, J.P.3
  • 16
    • 34447105854 scopus 로고    scopus 로고
    • The Framingham pre-dictive instrument in chronic kidney disease
    • Weiner DE, Tighiouart H, Elsayed EF, et al. The Framingham pre-dictive instrument in chronic kidney disease. J Am Coll Cardiol 2007; 50: 217.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 217
    • Weiner, D.E.1    Tighiouart, H.2    Elsayed, E.F.3
  • 17
    • 70349976327 scopus 로고    scopus 로고
    • Using nontraditional risk factors in coronary heart disease risk assessment: U.S. preventive services task force recommendation statement
    • U.S. Preventive Services Task Force
    • U.S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. preventive services task force recommendation statement. Ann Intern Med 2009;151: 474.
    • (2009) Ann Intern Med , vol.151 , pp. 474
  • 18
    • 70349972800 scopus 로고    scopus 로고
    • Emerging risk factors for coronaryheart disease: A summaryofsystematic reviews conducted for the U.S Preventive Services Task Force
    • Helfand M, Buckley DI, Freeman M, et al. Emerging risk factors for coronaryheart disease: A summaryofsystematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151:496.
    • (2009) Ann Intern Med , vol.151 , pp. 496
    • Helfand, M.1    Buckley, D.I.2    Freeman, M.3
  • 19
    • 33747120659 scopus 로고    scopus 로고
    • Using standardized serum creatinine values in the modification ofdiet in renal disease study equation for estimating glo-merular filtration rate
    • Chronic Kidney Disease Epidemi-ology Collaboration
    • Levey AS, Coresh J, Greene T, et al; Chronic Kidney Disease Epidemi-ology Collaboration. Using standardized serum creatinine values in the modification ofdiet in renal disease study equation for estimating glo-merular filtration rate. Ann Intern Med 2006; 145: 247.
    • (2006) Ann Intern Med , vol.145 , pp. 247
    • Levey, A.S.1    Coresh, J.2    Greene, T.3
  • 20
    • 54349117353 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32(suppl 1): S1.
    • (2008) Can J Diabetes , vol.32 , Issue.SUPPL. 1
  • 21
    • 10744229858 scopus 로고    scopus 로고
    • Effect of fluva-statin on cardiac outcomes in renal transplant recipients: A multicen-tre randomized placebo-controlled trial
    • Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators
    • Holdaas H, Fellstrom B, Jardine AG, et al.; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators. Effect of fluva-statin on cardiac outcomes in renal transplant recipients: A multicen-tre, randomized, placebo-controlled trial. Lancet 2003; 361: 2024.
    • (2003) Lancet , vol.361 , pp. 2024
    • Holdaas, H.1    Fellstrom, B.2    Jardine, A.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.